GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Short Percentage of Float

Spectral Medical (TSX:EDT) Short Percentage of Float


View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Spectral Medical's Short Percentage of Float

For the Diagnostics & Research subindustry, Spectral Medical's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spectral Medical's Short Percentage of Float Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Spectral Medical's Short Percentage of Float falls into.


Spectral Medical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Short Percentage of Float
Comparable Companies
TSXV:AVCR XCNQ:SONA XCNQ:BUX TSXV:TELO TSXV:ARC XCNQ:IZO XCNQ:VTAL TSXV:MBI.H TMO DHR XSWX:LONN IQV A IDXX MTD ICLR ILMN WAT LH DGX
Traded in Other Exchanges
EDTXF:USA SD4:Germany
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Website
https://www.spectraldx.com
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.
Executives
Anthony Phillip Bihl Director
William Charles Stevens Director

Spectral Medical Headlines